ANIP - ANI Pharmaceuticals Inc Stock Price, Fair Value and News

$82.70+0.58 (+0.71%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ANIP Price Action

Last 7 days

-2.0%

Last 30 days

-12.1%

Last 90 days

-13.8%

Trailing 12 Months

45.4%

ANIP RSI Chart

ANIP Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

41.27

Price/Sales (Trailing)

2.01

EV/EBITDA

10.01

Price/Free Cashflow

10.66

ANIP Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ANIP Fundamentals

ANIP Revenue

Revenue (TTM)

826.9M

Rev. Growth (Yr)

53.58%

Rev. Growth (Qtr)

7.78%

ANIP Earnings

Earnings (TTM)

40.2M

Earnings Growth (Yr)

210.14%

Earnings Growth (Qtr)

211.35%

ANIP Profitability

Operating Margin

89.68%

EBT Margin

6.11%

Return on Equity

7.95%

Return on Assets

2.86%

Free Cashflow Yield

9.38%

ANIP Investor Care

Shares Dilution (1Y)

3.45%

Diluted EPS (TTM)

1.68

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	674.1M	747.4M	826.9M	0
2024	517.5M	539.0M	555.5M	614.4M
2023	358.7M	401.4M	449.4M	486.8M
2022	226.1M	251.3M	283.1M	316.4M
2021	213.2M	213.4M	212.5M	216.1M
2020	203.4M	197.5M	199.2M	208.5M
2019	208.0M	215.1M	215.7M	206.5M
2018	186.7M	189.2M	191.7M	201.6M
2017	144.7M	158.1M	167.8M	176.8M
2016	78.1M	89.9M	108.5M	128.6M
2015	63.9M	76.7M	79.3M	76.3M
2014	35.4M	35.9M	45.5M	56.0M
2013	17.8M	18.7M	21.5M	30.1M
2012	5.4M	10.4M	15.4M	20.4M
2011	2.0M	1.5M	944.9K	435.2K
2010	0	0	0	2.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

CEO	Mr. Nikhil Lalwani
WEBSITE	anipharmaceuticals.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	600

ANI Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for ANI Pharmaceuticals Inc? What does ANIP stand for in stocks?

ANIP is the stock ticker symbol of ANI Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ANI Pharmaceuticals Inc (ANIP)?

As of Wed Dec 03 2025, market cap of ANI Pharmaceuticals Inc is 1.66 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ANIP stock?

You can check ANIP's fair value in chart for subscribers.

Is ANI Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether ANIP is over valued or under valued. Whether ANI Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact ANI Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ANIP.

What is ANI Pharmaceuticals Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ANIP's PE ratio (Price to Earnings) is 41.27 and Price to Sales (PS) ratio is 2.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ANIP PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on ANI Pharmaceuticals Inc's stock?

In the past 10 years, ANI Pharmaceuticals Inc has provided 0.065 (multiply by 100 for percentage) rate of return.